Tseng TingTing, Uen WuChing, Tseng JenChih, Lee ShaoChen
School of Medicine, Fu Jen Catholic University, New Taipei City 242, Taiwan.
Department of Hematology and Oncology, Shin Kong Wu Ho-Su Memorial Hospital, Taipei City 111, Taiwan.
Oncotarget. 2017 Jun 27;8(37):61528-61537. doi: 10.18632/oncotarget.18616. eCollection 2017 Sep 22.
Syndecan family proteins are heparan sulfate proteoglycans, which involved in various cellular activities and associating with metastatic potential and chemosensitivity of tumor cells. Melanoma is one of malignant tumors with poor prognosis upon metastasis. Previously, we had shown that melanoma cells remained survived under cell detachment, which was similar to the initial steps of tumor metastasis. Downregulation of syndecan-1 and upregulation of syndecan-2 in melanoma A375 cells were observed by different suspension conditions. Specific gene alterations also increased melanoma malignancy under anchorage independency. Thus, we would like to investigate in further the role of specific gene alteration, so that it could be used to develop novel strategy to treat melanoma. In this paper, we found that syndecan-2 expression level as well the kinase phosphorylation levels increased upon anchorage independency. The pathway to regulate syndecan-2 expression shifted from PKCα/β-dependent under adhesion into PKCδ-dependent under cell suspension. Manipulation of syndecan-2 expression showed that PI3K and ERK phosphorylation as well the migratory ability increased with increased syndecan-2 expression level. In addition, suspended melanoma cells were more sensitive to chemoagents, which correlated with syndecan-2 overexpression, PI3K and ERK activations, serum level, and the presence of glycosaminoglycans. In conclusion, we showed upregulation of syndecan-2 in anoikis-resistant melanoma cells enhanced chemosensitivity through PI3K and ERK activation. This observation would support and refine the strategy of adjuvant chemotherapy to overcome metastatic melanoma.
Syndecan家族蛋白是硫酸乙酰肝素蛋白聚糖,参与多种细胞活动,并与肿瘤细胞的转移潜能和化学敏感性相关。黑色素瘤是转移后预后较差的恶性肿瘤之一。此前,我们已经表明黑色素瘤细胞在细胞脱离状态下仍能存活,这与肿瘤转移的初始步骤相似。在不同的悬浮条件下,观察到黑色素瘤A375细胞中syndecan-1下调和syndecan-2上调。特定基因改变在非锚定依赖性条件下也增加了黑色素瘤的恶性程度。因此,我们希望进一步研究特定基因改变的作用,以便用于开发治疗黑色素瘤的新策略。在本文中,我们发现非锚定依赖性条件下syndecan-2表达水平以及激酶磷酸化水平增加。调节syndecan-2表达的途径从黏附状态下的PKCα/β依赖性转变为细胞悬浮状态下的PKCδ依赖性。对syndecan-2表达的调控表明,PI3K和ERK磷酸化以及迁移能力随着syndecan-2表达水平的增加而增加。此外,悬浮的黑色素瘤细胞对化疗药物更敏感,这与syndecan-2过表达、PI3K和ERK激活、血清水平以及糖胺聚糖的存在相关。总之,我们表明抗失巢凋亡的黑色素瘤细胞中syndecan-2上调通过PI3K和ERK激活增强了化学敏感性。这一观察结果将支持并完善辅助化疗以克服转移性黑色素瘤的策略。